Ten things you learned in your residency about retinoblastoma that have changed the 2023 Victor T. Curtin Lecture
- PMID: 36995014
- PMCID: PMC10688026
- DOI: 10.1080/13816810.2023.2189948
Ten things you learned in your residency about retinoblastoma that have changed the 2023 Victor T. Curtin Lecture
Abstract
Retinoblatoma is now the pediatric cancer with the highest cure rate. More than any other ocular malignancy the approach to this cancer has changed dramatically in the past 10 years. Most of the things taught to the majority of all Ophthalmology residents is out of date. Because few Ophthalmologists deal with retinoblastoma they are not aware of these seismic changes so this summary of my Curtin lectures outlines some of the major changes all Ophthalmologists should be familiar with.
Keywords: PGD; RB1; Retinoblastoma; cancer; choroidal invasion; intraarterial chemotherapy; intravitreal chemotherapy; melphalan; radiation.
Figures
References
-
- Munier FL, Beck-Popovic M, Chantada GL, Cobrinik D, Kivelä TT, Lohmann D, et al. Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. “Alive, with good vision and no comorbidity”. Prog Retin Eye Res. 2019;73:100764. - PubMed
-
- Abramson DH. The focal treatment of retinoblastoma with emphasis on xenon arc photocoagulation. Acta Ophthalmol Suppl (1985). 1989;194:3–63. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous